Arriving in the landscape of weight management therapy, retatrutide is a unique strategy. Unlike many existing medications, retatrutide works as a twin agonist, simultaneously targeting both GLP peptide-1 (GLP-1) and glucose-dependent insulinotropic hormone (GIP) receptors. The simultaneous stimulation encourages several advantageous effects, like